mRNA |
MI-1 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
BRD-K35604418 |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.021 |
0.6 |
mRNA |
Erlotinib |
gCSI |
pan-cancer |
AAC |
-0.033 |
0.6 |
mRNA |
BRD-K63431240 |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
paclitaxel |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
BRD-K78574327 |
CTRPv2 |
pan-cancer |
AAC |
-0.04 |
0.6 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.02 |
0.6 |
mRNA |
PD 153035 |
CTRPv2 |
pan-cancer |
AAC |
0.024 |
0.6 |